High Potency Pancreatin Pharmaceutical Compositions

Patent No. EP3024479 (titled "High Potency Pancreatin Pharmaceutical Compositions") was filed by Allergan Pharmaceuticals on Jul 15, 2014. The application was issued on Feb 8, 2023.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
MATHYS & SQUIRE	Mar 5, 2020	MATHYS & SQUIRE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jan 12, 2023
Decision to maintain the European patent in amended form
Jan 12, 2023
Decision to maintain the European patent in amended form
Jan 10, 2023
Termination of the opposition proceedings with maintenance of patent
Jan 2, 2023
(Electronic) Receipt
Jan 2, 2023
Filing of the translation of the amended claims
Jan 2, 2023
French translation of claims
Jan 2, 2023
German translation of the claims
Jan 2, 2023
Letter accompanying subsequently filed items
Sep 23, 2022
Communication of bibliographic data
Sep 23, 2022
Communication to opponent concerning maintenance
Sep 23, 2022
Communication with request to file translations
Sep 16, 2022
Maintenance of the patent with the documents specified in the final decision
Jul 6, 2022
Refund of fees
Jun 29, 2022
F3324 Closure of the appeal proceedings: withdrawal of the appeal/ application/ opposition
Jun 29, 2022
F3324 Closure of the appeal proceedings: withdrawal of the appeal/ application/ opposition
Jun 21, 2022
Composition of the board (T)
Jun 21, 2022
F3345 Forwarding of submissions to parties
Jun 15, 2022
(Electronic) Receipt
Jun 15, 2022
Letter accompanying subsequently filed items
Jun 15, 2022
Withdrawal of an appeal
May 20, 2022
F3204 Communication of the file number to the parties
May 19, 2022
(Electronic) Receipt
May 19, 2022
Letter accompanying subsequently filed items
May 19, 2022
Notice of appeal
Mar 11, 2022
Advice of delivery
Mar 11, 2022
Advice of delivery
Mar 9, 2022
Advice of delivery
Mar 9, 2022
Annex to the communication - opposition
Mar 9, 2022
Decision of the Opposition Division and instruction
Mar 9, 2022
Druckexemplar in opposition procedure
Mar 9, 2022
Grounds for the decision (Annex) - opposition
Mar 9, 2022
Interlocutory decision in opposition proceedings
Mar 9, 2022
Interlocutory decision in opposition proceedings
Mar 9, 2022
Means of redress
Mar 9, 2022
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Mar 9, 2022
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Mar 9, 2022
Minutes of the oral proceedings (Opposition Division) - introduction of the parties
Mar 9, 2022
Provision of a copy of the minutes - opposition procedure
Mar 9, 2022
Provision of a copy of the minutes - opposition procedure
Mar 9, 2022
Scanned annex to a communication - opposition procedure
Mar 9, 2022
Scanned annex to a communication - opposition procedure
Mar 9, 2022
Transmittal of decision / summons - opposition
Mar 9, 2022
Transmittal of decision / summons - opposition
Jan 19, 2022
Information about the result of oral proceedings
Nov 29, 2021
Brief communication - Opposition proceedings
Nov 24, 2021
(Electronic) Receipt
Nov 24, 2021
(Electronic) Receipt
Nov 24, 2021
Brief communication - Opposition proceedings
Nov 24, 2021
Brief communication - Opposition proceedings
Nov 24, 2021
Letter accompanying subsequently filed items
Nov 24, 2021
Letter accompanying subsequently filed items
Nov 24, 2021
Written submission in preparation to/during oral proceedings
Nov 19, 2021
(Electronic) Receipt
Nov 19, 2021
(Electronic) Receipt
Nov 19, 2021
Auxiliary request during Opposition procedure
Nov 19, 2021
Auxiliary request during Opposition procedure
Nov 19, 2021
Auxiliary request during Opposition procedure
Nov 19, 2021
Auxiliary request during Opposition procedure
Nov 19, 2021
Auxiliary request during Opposition procedure
Nov 19, 2021
Auxiliary request during Opposition procedure
Nov 19, 2021
Auxiliary request during Opposition procedure - 01
Nov 19, 2021
Auxiliary request during Opposition procedure - 02
Nov 19, 2021
Auxiliary request during Opposition procedure - 03
Nov 19, 2021
Auxiliary request during Opposition procedure - 04
Nov 19, 2021
Auxiliary request during Opposition procedure - 05
Nov 19, 2021
Auxiliary request during Opposition procedure - 06
Nov 19, 2021
Citation in opposition procedure - 012
Nov 19, 2021
Consolidated list of cited opposition documents
Nov 19, 2021
Letter accompanying subsequently filed items
Nov 19, 2021
Letter accompanying subsequently filed items
Nov 19, 2021
Request for interpreters during oral proceedings
Nov 19, 2021
Written submission in preparation to/during oral proceedings
Nov 19, 2021
Written submission in preparation to/during oral proceedings
Aug 27, 2021
Notification concerning the date of oral proceedings
Aug 27, 2021
Notification concerning the date of oral proceedings
Mar 8, 2021
Advice of delivery
Mar 5, 2021
Advice of delivery
Mar 1, 2021
Annex to the communication - opposition
Mar 1, 2021
Information concerning oral proceedings
Mar 1, 2021
Summons to attend oral proceedings
Mar 1, 2021
Summons to attend oral proceedings
Mar 1, 2021
Transmittal of decision / summons - opposition
Mar 1, 2021
Transmittal of decision / summons - opposition
Mar 1, 2021
Transmittal of decision / summons - opposition
Mar 1, 2021
Transmittal of decision / summons - opposition
Sep 18, 2020
Communication of amended entries concerning the representative
Sep 14, 2020
Letter accompanying subsequently filed items
Sep 14, 2020
Letter accompanying subsequently filed items
Sep 14, 2020
Submission concerning change of applicant's representative
Aug 7, 2020
Brief communication - Opposition proceedings
Aug 7, 2020
Grant of extension of time limit (opposition procedure)
Jul 31, 2020
(Electronic) Receipt
Jul 31, 2020
Any annexes (other than citation) to an opposition letter
Jul 31, 2020
Any annexes (other than citation) to an opposition letter
Jul 31, 2020
Fax filed during the opposition procedure
Jul 31, 2020
Letter accompanying subsequently filed items
Jul 31, 2020
Request for extension of time limit
Jul 31, 2020
Request for extension of time limit
Jul 15, 2020
Brief communication - Opposition proceedings
Jul 14, 2020
Communication confirming withdrawal from representation
Jul 14, 2020
Communication of amended entries concerning the representative
Jul 9, 2020
(Electronic) Receipt
Jul 9, 2020
Letter accompanying subsequently filed items
Jul 9, 2020
Submission concerning change of proprietor's representative
Mar 31, 2020
Communication of a notice of opposition and request to file observations
Mar 31, 2020
Notice of further oppositions to opponent(s)
Mar 20, 2020
Communication of a notice of opposition - first information to patent proprietor
Mar 19, 2020
Document concerning representation
Mar 5, 2020
(Electronic) Receipt
Mar 5, 2020
Any annexes (other than citation) to an opposition letter
Mar 5, 2020
Citation in opposition procedure - 001
Mar 5, 2020
Citation in opposition procedure - 002
Mar 5, 2020
Citation in opposition procedure - 003
Mar 5, 2020
Citation in opposition procedure - 004
Mar 5, 2020
Citation in opposition procedure - 005
Mar 5, 2020
Citation in opposition procedure - 006
Mar 5, 2020
Citation in opposition procedure - 007
Mar 5, 2020
Citation in opposition procedure - 008
Mar 5, 2020
Citation in opposition procedure - 009
Mar 5, 2020
Citation in opposition procedure - 010
Mar 5, 2020
Citation in opposition procedure - 011
Mar 5, 2020
International publication (Pamphlet)
Mar 5, 2020
Notice of opposition
Mar 5, 2020
Notice of opposition
Mar 5, 2020
Notice of opposition
Jun 18, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
May 9, 2019
Decision to grant a European patent
Apr 25, 2019
(Electronic) Receipt
Apr 25, 2019
Filing of the translations of the claims
Apr 25, 2019
French translation of claims
Apr 25, 2019
German translation of the claims
Apr 25, 2019
Letter accompanying subsequently filed items
Mar 25, 2019
Communication of the registration of a transfer or change of name and/or address
Mar 4, 2019
(Electronic) Receipt
Mar 4, 2019
Annexes in respect of a client data request
Mar 4, 2019
Letter accompanying subsequently filed items
Mar 4, 2019
Submission concerning change of applicant's name
Mar 1, 2019
Bibliographic data of the European patent application
Mar 1, 2019
Communication about intention to grant a European patent
Mar 1, 2019
Intention to grant (signatures)
Mar 1, 2019
Text intended for grant (clean copy)
Mar 1, 2019
Text intended for grant (version for approval)
Dec 20, 2018
Communication of amended entries concerning the representative
Dec 14, 2018
Submission concerning change of applicant's representative
Dec 13, 2018
Submission concerning change of applicant's representative
Mar 20, 2018
(Electronic) Receipt
Mar 20, 2018
Amended claims with annotations
Mar 20, 2018
Claims
Mar 20, 2018
Letter accompanying subsequently filed items
Mar 20, 2018
Reply to communication from the Examining Division
Jan 12, 2018
Grant of extension of time limit (examination procedure)
Jan 8, 2018
(Electronic) Receipt
Jan 8, 2018
Letter accompanying subsequently filed items
Jan 8, 2018
Request for extension of time limit to communication from the Examining Division
Sep 15, 2017
Annex to the communication
Sep 15, 2017
Communication from the Examining Division
Sep 11, 2017
Examination started
Sep 8, 2016
(Electronic) Receipt
Sep 8, 2016
Amended claims filed after receipt of (European) search report
Sep 8, 2016
Amended claims with annotations
Sep 8, 2016
Amendments received before examination
Sep 8, 2016
Letter accompanying subsequently filed items
May 13, 2016
Communication to designated inventor
May 4, 2016
(Electronic) Receipt
May 4, 2016
Letter accompanying subsequently filed items
May 4, 2016
Letter concerning the inventor
May 4, 2016
Notification on forthcoming publication of bibliographic data
May 2, 2016
Invitation to indicate correct address of inventor
Apr 25, 2016
Letter which had not been notified
Mar 22, 2016
Communication concerning corrected entries of the applicant
Mar 3, 2016
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Feb 26, 2016
Communication to designated inventor
Feb 26, 2016
Communication to designated inventor
Feb 26, 2016
Communication to designated inventor
Feb 26, 2016
Communication to designated inventor
Feb 26, 2016
Communication to designated inventor
Feb 8, 2016
Copy of the international preliminary report on patentability
Jan 19, 2016
(Electronic) Receipt
Jan 19, 2016
Request for entry into the European phase
Jan 19, 2016
Submission concerning representation
Dec 16, 2015
Information on entry into European phase
Nov 11, 2015
Notification of the recording of a change
May 28, 2015
Copy of the international search report
May 28, 2015
International publication of the international search report
May 12, 2015
Notification of the recording of a change
Mar 11, 2015
Notification of the recording of a change
Mar 11, 2015
Notification of the recording of a change
Mar 11, 2015
Notification of the recording of a change
Mar 11, 2015
Notification of the recording of a change
Mar 5, 2015
Priority document (electronically transmitted)
Feb 27, 2015
Written opinion of the ISA, boxes No. I to VIII
Feb 27, 2015
Written opinion of the ISA, cover sheet
Feb 27, 2015
Written opinion of the ISA, supplemental box
Feb 12, 2015
Published international application - A2
Dec 19, 2014
Abstract
Dec 19, 2014
Claims
Dec 19, 2014
Description

EP3024479

ALLERGAN PHARMACEUTICALS

Application Number: EP14815008A
Filing Date: Jul 15, 2014
Status: Patent Maintained As Amended; Jan 6, 2023
Publication Date: Feb 8, 2023
External Links: Slate, Register , Google Patents

IP Verse

High Potency Pancreatin Pharmaceutical Compositions

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3024479